J. B. Ursing - Infectious Diseases

Author Information

Johan Ursing is affiliated with the Department of Infectious Diseases at Danderyd Hospital in Stockholm, Sweden. His research focuses primarily on infectious diseases, with a particular emphasis on malaria and COVID-19. Through his work, he contributes significantly to understanding the dynamics of infectious diseases and their treatment.

Research Contributions

Johan Ursing has made substantial contributions to the study of infectious diseases, particularly malaria and COVID-19. His recent work includes meta-analyses on the temporal distribution of Plasmodium falciparum recrudescence following artemisinin-based combination therapy and analyses of haematological consequences of acute uncomplicated falciparum malaria. He has also explored therapeutic approaches for COVID-19, such as convalescent plasma treatment, and investigated the prevalence of diarrhoeal pathogens in Guinea-Bissau. His research is characterized by a focus on both the biological and clinical aspects of infectious disease management.

Aliases

Johan Ursing is also known by several aliases in academic publications, including Jan Ursing, J Ursing, J. B. Ursing, J. Ursing, and J B Ursing. These variations may appear in different databases or publications.

Publication and Citation Metrics

Metric	Value
Citation Count	4675
h-index	37
Paper Count	160

Publications:

Temporal distribution of Plasmodium falciparum recrudescence following artemisinin-based combination therapy: an individual participant data meta-analysis

DOI: 10.1186/s12936-021-03980-z

Year: 2022

Haematological consequences of acute uncomplicated falciparum malaria: a WorldWide Antimalarial Resistance Network pooled analysis of individual patient data

DOI: 10.1186/s12916-022-02265-9

Year: 2022

Chloroquine-susceptible and -resistant Plasmodium falciparum strains survive high chloroquine concentrations by becoming dormant but are eliminated by prolonged exposure

DOI: 10.1093/jac/dkac008

Year: 2022

Duration of SARS-CoV-2 viremia and its correlation to mortality and inflammatory parameters in patients hospitalized for COVID-19: a cohort study

DOI: 10.1016/j.diagmicrobio.2021.115595

Year: 2021

Convalescent plasma for treatment of COVID-19: study protocol for an open randomised controlled trial in Sweden

DOI: 10.1136/bmjopen-2020-048337

Year: 2021

Prevalence of diarrhoeal pathogens among children under five years of age with and without diarrhoea in Guinea-Bissau

DOI: 10.1371/journal.pntd.0009709

Year: 2021

SARS-CoV-2 RNA in serum as predictor of severe outcome in COVID-19: a retrospective cohort study.

DOI: 10.1093/cid/ciaa1285

Year: 2020

Seasonal variation in the non-specific effects of BCG vaccination on neonatal mortality: three randomised controlled trials in Guinea-Bissau

DOI: 10.1136/bmjgh-2019-001873

Year: 2020

Stable high frequencies of sulfadoxine-pyrimethamine resistance associated mutations and absence of K13 mutations in Plasmodium falciparum 3 and 4 years after the introduction of artesunate plus sulfadoxine-pyrimethamine in Ujjain, Madhya Pradesh, India

DOI: 10.21203/rs.2.21394/v2

Year: 2020

Stable high frequencies of sulfadoxine-pyrimethamine resistance associated mutations and absence of K13 mutations in Plasmodium falciparum 3 and 4 years after the introduction of artesunate plus sulfadoxine-pyrimethamine in Ujjain, Madhya Pradesh, India

DOI: 10.21203/rs.2.21394/v1

Year: 2020

How Does the CDC Monitor Infectious Diseases?

What is Symptomatic Relief?

Why is Respiratory Hygiene Important?

How Do Culex Mosquitoes Transmit Diseases?

What is the World Health Organization (WHO)?

How is it diagnosed?

Why Are Infectious Diseases a Global Health Concern?

What are the Challenges in Controlling Anopheles Mosquitoes?

What diseases does it cause?

What is COVID-19?

Partnered Content Networks

Relevant Topics